Therapy for primary CNS lymphoma has evolved greatly in recent years. The life expectancy of patients has increased. Methotrexate remains the basis of all induction therapies. In consolidation, the situation is somewhat less clear.
Therapy for primary CNS lymphoma has evolved greatly in recent years. The life expectancy of patients has increased. Methotrexate remains the basis of all induction therapies. In consolidation, the situation is somewhat less clear.
Input your search keywords and press Enter.